490 filings
Page 5 of 25
6-K
c72q5tg
20 May 21
Neovasc Provides Update on German Litigation
4:28pm
6-K
zfmioov2
13 May 21
Current report (foreign)
2:29pm
6-K
3qchi7b0 rt
10 May 21
Neovasc Announces First Patient Enrollment in COSIMA Trial
3:50pm
6-K
wdjmrbcpkr5rpcohfti
6 May 21
Condensed Interim Consolidated Financial Statements
4:06pm
6-K
cu3h zfztctu77xn
6 May 21
Neovasc Announces First Quarter 2021 Financial Results
4:05pm
F-10/A
rykgquf8 p9y2xwjr98
4 May 21
Registration of securities (Canada) (amended)
6:31am
6-K
047bb7xn7azq8yq22 b0
4 May 21
Form 51-102F3 Material Change Report
12:00am
6-K
x2mhpb 0zv03tu1ba3
28 Apr 21
Neovasc Provides Reducer Reimbursement Progress Update
9:07am
6-K
ky8p1j 6cdl9kblfp
27 Apr 21
Current report (foreign)
9:07am
6-K
kl3i626f4km1fjb
19 Apr 21
Current report (foreign)
9:30am
F-X
b1vdf21k9yu2t
16 Apr 21
Appointment of agent for service of process by issuers registering securities
2:11pm
F-10
lqsakuqbkq5iv5c7usj
16 Apr 21
Registration of securities (Canada)
1:42pm
6-K
2xhp4fzkpypgy68lch1q
16 Apr 21
Neovasc Provides Tiara TA Update
9:58am
40-F
2z5zb
11 Mar 21
Annual report (Canada)
4:44pm
6-K
2vaznkt nmp
11 Mar 21
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
4:07pm
6-K
w5esy sqn
4 Mar 21
Current report (foreign)
9:03am
6-K
1x4vn4sf
3 Mar 21
Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
4:57pm
6-K
fukt8jbs3m630c2slo
2 Mar 21
Current report (foreign)
9:07am
6-K
ha0bq 6wh6w4
24 Feb 21
Current report (foreign)
4:07pm
6-K
mtswkvzqauztqqtz8aoe
23 Feb 21
FormĀ 51-102F3 Material Change Report
12:00am